Even though QA is generally associated with a finished product, during the drug development process, there is always ongoing safety oversight at every stage. At Novartis, programs focus on early phase clinical trials, so Kaitlin has a unique perspective on QA as someone who is primarily involved at the beginning of the drug development process. Read more to learn about what inspired her to pursue a fellowship in early phase quality assurance and what she's most proud of from her first year.
Meet Mary Bylo, one of our Novartis CS&I fellows! Learn about what makes the Novartis program unique and how Mary decided to pursue a fellowship.
One of the many benefits of participating in a fellowship program is the program's alumni network. After completing her fellowship in June 2018, Amanda Nguyen accepted a position at her fellowship company and volunteered to serve as one of the MFN's alumni representatives. Learn about a clinical scientist's role, and read about Amanda's reflection on her time as a fellow and how Novartis prepared her to take on the challenges of her current position.